Publications
5802 Results
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 12018) (American Society of Clinical Oncology Annual Meeting 2021, poster discussion)
- Year
- 2021
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1200
Long-term Results from a Randomized Blinded Sham- and Waitlist-Controlled Trial of Acupuncture for Joint Symptoms Related to Aromatase Inhibitors in Early Stage Breast Cancer (S1200)
- Journal / Conference
- American Journal of Clinical Nutrition, Oct 4;114(4):1408-1417
- Year
- 2021
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID34258619
- PMC
- PMC8488877
- Study Number(s)
- S0000, SWOG-9217
Hepcidin-regulating iron-metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies
- Journal / Conference
- Prostate Cancer and Prostatic Diseases Jun 14. doi: 10.1038/s41391-021-00403-7. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID34127801
- PMC
- PMC8669040
- Study Number(s)
- S0000, SWOG-9217
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24
- Journal / Conference
- JAMA Onc. 2021 Sep 1;7(9):1368-1377
- Year
- 2021
- Research Committee(s)
- Lung
- PMID
- PMID34264316
- PMC
- PMC8283667
- Study Number(s)
- S1400I
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial
- Journal / Conference
- JNCI Cancer Spectrum Apr 12;5(3):pkab034
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34104867
- PMC
- PMC8178799
- Study Number(s)
- C89803
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
- Journal / Conference
- Pharmacogenetics and Genomics Dec 1;31(9):215-220
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34149004
- PMC
- PMC8490297
Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/Leucovorin or Epirubicin/Cisplatin/Fluorouracil Before and After Chemoradiation on CALGB (Alliance) 80101
- Journal / Conference
- Breast Cancer Research and Treatment Jul;188(2):477-487
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID33852121
- PMC
- PMC8262517
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology, Aug 10;39(23):2539-2551; Jun 6;JCO2100976. doi: 10.1200/JCO.21.00976. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID34092112
- Study Number(s)
- CTSU/EA1131
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131
- Journal / Conference
- Contemporary Clinical Trials Oct;109:106519
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID34333138
- PMC
- PMC8665835
- Study Number(s)
- S0820
Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial
- Journal / Conference
- Cancer, Dec 15;127(24):4574-4584
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID34351619
- PMC
- PMC8665001